Habib J Dable Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Habib J Dable is of Blueprint Medicines Corp. Currently has a direct ownership of 8,742 shares of BPMC, which is worth approximately $788,003. The most recent transaction as insider was on Jun 12, 2024, when has been sold 2,242 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.74K
0% 3M change
34.49% 12M change
Total Value Held $788,003

Habib J Dable Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
2,242 Added 20.41%
8,742 Common Stock
Jun 21 2023
BUY
Grant, award, or other acquisition
-
2,600 Added 28.57%
6,500 Common Stock
Jun 23 2022
BUY
Grant, award, or other acquisition
-
3,900 Added 50.0%
3,900 Common Stock

Also insider at

DAWN
Day One Biopharmaceuticals, Inc. Healthcare
AVTE
Aerovate Therapeutics, Inc. Healthcare
ALBO
ALBIREO PHARMA, INC. Healthcare
Director
PEPG
PepGen Inc. Healthcare
Director
XLRN
ACCELERON PHARMA INC Healthcare
CEO and President
HJD

Habib J Dable

Boston, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC